Nau G J, Moldwin R L, Lancki D W, Kim D K, Fitch F W
J Immunol. 1987 Jul 1;139(1):114-22.
Both cloned murine helper T lymphocytes (HTL) and cytolytic T lymphocytes (CTL) proliferated and secreted lymphokines when stimulated with immobilized anti-T cell receptor monoclonal antibody (anti-TCR mAb). However, although proliferation of CTL increased and reached plateau levels as concentrations of anti-TCR mAb were increased, the proliferation of HTL decreased with high concentrations of anti-TCR mAb. A reduction of IL 2-dependent proliferation by CTL was observed when IL 2 was added to cultures of CTL in the presence of high concentrations of anti-TCR mAb, whereas IL 2-independent proliferation appeared to be unaffected by these concentrations of anti-TCR mAb. Inhibition of IL 2-driven proliferation caused by high concentrations of immobilized anti-TCR mAb did not seem to be mediated by soluble factors. Cells continued to express cell surface receptors for IL 2 and transferrin after treatment with immobilized anti-TCR mAb. Inhibition of IL 2-driven proliferation by high concentrations of immobilized anti-TCR mAb may represent a mechanism for regulating the proliferation of T lymphocytes. This inhibitory mechanism is initiated by stimulation of the T cell receptor, in this case by immobilized anti-TCR mAb, and is independent of other cells and factors.
当用固定化抗T细胞受体单克隆抗体(抗TCR mAb)刺激时,克隆的小鼠辅助性T淋巴细胞(HTL)和细胞毒性T淋巴细胞(CTL)均会增殖并分泌淋巴因子。然而,尽管随着抗TCR mAb浓度的增加,CTL的增殖增加并达到平台期水平,但高浓度抗TCR mAb会使HTL的增殖降低。当在高浓度抗TCR mAb存在的情况下将IL-2添加到CTL培养物中时,观察到CTL对IL-2依赖性增殖的降低,而这些浓度的抗TCR mAb似乎对IL-2非依赖性增殖没有影响。高浓度固定化抗TCR mAb引起的IL-2驱动的增殖抑制似乎不是由可溶性因子介导的。用固定化抗TCR mAb处理后,细胞继续表达IL-2和转铁蛋白的细胞表面受体。高浓度固定化抗TCR mAb对IL-2驱动的增殖的抑制可能代表了一种调节T淋巴细胞增殖的机制。这种抑制机制是由T细胞受体的刺激引发的,在这种情况下是由固定化抗TCR mAb引发的,并且独立于其他细胞和因子。